Movement disorders in 2011: Translating new research findings into clinical practice

Christine Klein; Dimitri Krainc

doi:10.1038/nrneurol.2011.212

Movement disorders in 2011: Translating new research findings into clinical practice

Christine Klein^*, Dimitri Krainc

^*Corresponding author for this work

Institute of Neurogenetics

Harvard University

2 Citations (Scopus)

Abstract

The discovery of mutations that contribute to movement disorders has facilitated the identification of converging pathways and novel therapeutic targets. Successful translation of these research findings into clinical practice will require identification of early markers of disease progression, and recent research indicates that progress is being made in this area.

Original language	English
Journal	Nature Reviews Neurology
Volume	8
Issue number	2
Pages (from-to)	65-66
Number of pages	2
ISSN	1759-4758
DOIs	https://doi.org/10.1038/nrneurol.2011.212
Publication status	Published - 02.2012

Funding

C. Klein is funded by a career development award from the Hermann and Lilly Schilling Foundation. D. Krainc is supported by the National Institute of Neurological Disorders and Stroke and the CHDI Foundation.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/nrneurol.2011.212

Cite this

@article{13cb3ff4507c46739b07886cc5f51733,

title = "Movement disorders in 2011: Translating new research findings into clinical practice",

abstract = "The discovery of mutations that contribute to movement disorders has facilitated the identification of converging pathways and novel therapeutic targets. Successful translation of these research findings into clinical practice will require identification of early markers of disease progression, and recent research indicates that progress is being made in this area.",

author = "Christine Klein and Dimitri Krainc",

note = "Funding Information: C. Klein is funded by a career development award from the Hermann and Lilly Schilling Foundation. D. Krainc is supported by the National Institute of Neurological Disorders and Stroke and the CHDI Foundation.",

year = "2012",

month = feb,

doi = "10.1038/nrneurol.2011.212",

language = "English",

volume = "8",

pages = "65--66",

journal = "Nature Reviews Neurology",

issn = "1759-4758",

publisher = "Nature Research",

number = "2",

}

TY - JOUR

T1 - Movement disorders in 2011: Translating new research findings into clinical practice

AU - Klein, Christine

AU - Krainc, Dimitri

N1 - Funding Information: C. Klein is funded by a career development award from the Hermann and Lilly Schilling Foundation. D. Krainc is supported by the National Institute of Neurological Disorders and Stroke and the CHDI Foundation.

PY - 2012/2

Y1 - 2012/2

N2 - The discovery of mutations that contribute to movement disorders has facilitated the identification of converging pathways and novel therapeutic targets. Successful translation of these research findings into clinical practice will require identification of early markers of disease progression, and recent research indicates that progress is being made in this area.

AB - The discovery of mutations that contribute to movement disorders has facilitated the identification of converging pathways and novel therapeutic targets. Successful translation of these research findings into clinical practice will require identification of early markers of disease progression, and recent research indicates that progress is being made in this area.

UR - https://www.scopus.com/pages/publications/84857038919

U2 - 10.1038/nrneurol.2011.212

DO - 10.1038/nrneurol.2011.212

M3 - Scientific review articles

C2 - 22187001

AN - SCOPUS:84857038919

SN - 1759-4758

VL - 8

SP - 65

EP - 66

JO - Nature Reviews Neurology

JF - Nature Reviews Neurology

IS - 2

ER -

Movement disorders in 2011: Translating new research findings into clinical practice

Abstract

Funding

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this